Universal Forest Products, Inc., through its subsidiaries, primarily designs, manufactures, and markets wood and wood-alternative products for retail building home centers and other retailers. Its products comprise dimensional lumber, such as preserved and unpreserved lumber, and various value-added products; and engineered wood products that comprise roof and floor trusses, wall panels, engineered floor systems, I-joists, and lumber packages. The company also offers structural lumber and other products, such as roof trusses, cut and shaped lumber, plywood, particle board, and dimensional lumber for the manufactured housing industry; engineered wood components for the residential construction market; and specialty wood packaging, and components and packing materials for various industries. In addition, it provides outdoor living products, including wood composite decking, decorative balusters, post caps, and plastic lattice; lawn and garden products, such as trellises and arches, as well as offers framing services for the residential market and forming products for concrete construction. The company sells its products in the United States and internationally. Universal Forest Products, Inc. was founded in 1955 and is headquartered in Grand Rapids, Michigan.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and markets consumer products worldwide. The company operates in two segments: Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as dental floss and pharmaceutical products for dentists and other oral health professionals; personal care products comprising liquid hand soaps, shower gels, bar soaps, deodorants, antiperspirants, shampoos, and conditioners; and home care products, such as dishwashing liquids, laundry and dishwashing detergents, household cleaners, oil soaps, bleaches, and fabric conditioners. The company also offers pet nutrition products for everyday nutritional needs; a range of therapeutic products to manage disease conditions; and various products with natural ingredients. Its principal trademarks include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet, and Hill's Ideal Balance. The company markets its pet nutrition products for dogs and cats through pet supply retailers and veterinarians. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Best Buy Co., Inc. operates as a multi-national, multi-channel retailer of technology products in the United States, Canada, China, and Mexico. Its stores offer consumer electronics consisting primarily of television and home theaters; digital cameras and camcorders; DVD and Blu-ray players; portable electronics, such as MP3 devices, headphones and speakers, car stereo, navigation and satellite radio; and all related accessories. The company's stores also provide computing and mobile phone products, including notebook and desktop computers, tablets and e-readers, mobile phones and related subscription service commissions, and related accessories; entertainment products, such as video gaming hardware and software, DVDs, Blu-rays, CDs, digital downloads, and computer software; and appliances, including large and small appliances, and kitchen and bath fixtures, including faucets, sinks, toilets, and bathtubs. It also offers extended warranty service contracts, technical support, product repair, delivery, and installation services, as well as offers snacks and beverages. The company operates e-commerce operations, retail stores, and call centers; and conducts operations under various names, such as Best Buy, including BestBuy.com and BestBuy.ca; Best Buy Mobile; Five Star; Future Shop, including FutureShop.ca; Geek Squad; Magnolia Audio Video; and Pacific Sales. The company was formerly known as Sound of Music, Inc. Best Buy Co., Inc. was founded in 1966 and is headquartered in Richfield, Minnesota.
Western Alliance Bancorporation operates as the bank holding company for Western Alliance Bank that provides various banking and related services in Nevada, Arizona, and California. The company operates through Bank of Nevada, Western Alliance Bank, Torrey Pines Bank, and Other segments. It accepts various deposit products, including checking accounts, savings accounts, and money market accounts, as well as other deposit accounts, such as fixed-rate and fixed maturity retail certificates of deposits. The company also offers a range of loan products comprising commercial and industrial loans, which include working capital lines of credit, inventory and accounts receivable lines, mortgage warehouse lines, equipment loans and leases, and other commercial loans; commercial real estate loans that are secured by apartment buildings, professional offices, industrial facilities, retail centers, and other commercial properties; construction and land development loans; residential real estate loans; and consumer loans, such as home equity loans and lines of credit, home improvement loans, and personal lines of credit. In addition, it provides other financial services consisting of Internet banking, wire transfers, electronic bill payment, lock box services, courier, and cash management services. Further, the company offers equipment finance; and holds and manages certain non-performing loans and other real estate owned. Western Alliance Bancorporation offers its services to businesses, professional firms, real estate developers and investors, local non-profit organizations, high net worth individuals, and other consumers. As of December 31, 2013, the company operated 39 branch locations. Western Alliance Bancorporation was founded in 1994 and is headquartered in Phoenix, Arizona.
8x8, Inc. provides unified communications and collaboration (UCC) services in the cloud for small and medium businesses, and mid-market and distributed enterprises. The company offers a suite of UCC services to in-office and mobile devices spanning cloud telephony, virtual contact center, and virtual meeting through a proprietary unified software-as-a-service platform. Its software abstracts complex networking, redundancy, security, and interconnection requirements to provide a solution for business customers. The company's software also integrates with enterprise resource planning, customer relationship management, human capital management, and other third-party application suites to provide organizations an integrated business communications and collaboration experience that is critical to operate their business. Its Infrastructure Manager software abstracts complex interconnectivity between Voice over IP, and public switched telephone network, enabling a turnkey UCC solution. The company's Integration Manager software integrates with third-party applications, allowing customers to access data while communicating with their clients or collaborating with colleagues. In addition, 8x8, Inc. sells pre-configured office phones. The company markets its services to end users through direct sales force, Website, and channel partners primarily in the United States. It serves more than 40,000 business customers with over 500,000 subscriptions. 8x8, Inc. was founded in 1987 and is headquartered in San Jose, California.
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. The company's Oncology Systems segment offers linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, and image processing software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, and cancer care clinics. Its X-Ray Products segment provides X-ray imaging components to large imaging system original equipment manufacturers (OEMs) for use in radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, and industrial applications; and X-ray tubes and flat panel digital image detectors to small OEMs, independent service companies, and end-users for filmless X-ray imaging. The company also designs, manufactures, sells, and services Linatron X-ray accelerators, imaging processing software, and image detection products for security and inspection purposes, such as cargo screening at ports and borders, and nondestructive examination in various applications. In addition, it offers products and systems for delivering proton therapy; and technologies in the areas of digital X-ray imaging, volumetric and functional imaging, and improved X-ray sources, as well as technology for security and cargo screening applications. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Synageva BioPharma Corp. operates as a biopharmaceutical company in the United States. It focuses on the discovery, development, and commercialization of therapeutic products for patients with rare diseases. The company's lead program include sebelipase alfa, a recombinant form of human lysosomal acid lipase (LAL), which is under Phase III clinical trials for the treatment of LAL deficiency in infants, children, and adults. It also has various other research programs in various stages of preclinical development, including SBC-103, an enzyme replacement therapy for lysosomal storage diseases, known as mucopolysaccharidosis type IIIB, as well as protein therapeutic programs for rare life-threatening diseases. The company was founded in 1996 and is headquartered in Lexington, Massachusetts.
zulily, Inc. operates as an online retailer. The company operates through two segments, North America and the United Kingdom. It provides various merchandise products to moms purchasing for their children, themselves, and their homes, including children's and women's apparel comprising accessories and shoes; children's merchandise comprising infant gear, sports equipment, toys, and books; and other merchandise, such as kitchen accessories, home dcor, entertainment, electronics, and pet accessories. The company sells its products through a flash sales model. zulily, Inc. was founded in 2009 and is headquartered in Seattle, Washington.
Revance Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic applications worldwide. Its lead product candidate is RT001, a topical gel formulation of botulinum toxin type A, which is in Phase III clinical trials for the treatment of crow's feet lines; has completed initial Phase II clinical trials for the treatment of hyperhidrosis and for the prevention of migraine headache; and has completed Phase I clinical trials for the treatment of other indications, such as neuropathic pain and rhinitis. The company is also developing RT002, a novel injectable formulation of botulinum toxin type A, which is being tested in the four-cohort Phase I/II clinical dose escalation trials for the treatment of glabellar lines. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark, California.
Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP nucleases (ZFNs) proteins, which could be used to modify DNA sequences in various ways; and ZFP transcription factors (ZFP TFs) proteins could be used to turn genes on or off. The company's principal ZFP therapeutic is SB-728-T, a ZFN-modified autologous T-cell product, which is in Phase II and Phase I/II clinical trials for the treatment of human immunodeficiency virus and acquired immunodeficiency syndrome. It also develops CERE-110 that is in Phase II clinical trial for the treatment of Alzheimer's disease. In addition, the company has ZFP therapeutic pre-clinical stage programs for hemophilia A and B, huntington's disease, and hemoglobinopathies; and proprietary programs in the areas of lysosomal storage disorders. Further, it has ZFP therapeutic research stage programs in the areas of other monogenic diseases, including various immunodeficiencies, as well as central nervous system disorders and cancer immunotherapy. The company has collaboration and license agreements with Shire International GmbH and Biogen Idec Inc.; and strategic partnerships with Sigma-Aldrich Corporation, Dow AgroSciences, LLC, Open Monoclonal Technology, Inc., F. Hoffmann-La Roche Ltd, and Hoffmann-La Roche Inc. Sangamo Biosciences, Inc. was founded in 1995 and is headquartered in Richmond, California.